Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|April 1, 2016
[Systemic therapy of metastatic renal cell carcinoma]Luise Maute, Lothar Bergmann
Expert Review of Anticancer Therapy|December 10, 2013
Temsirolimus for advanced renal cell carcinomaLothar Bergmann, Luise Maute, Michael Guschmann
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 16, 2011
The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell linesWolfgang Glienke, Luise Maute, Johannes Wicht, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2009
Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cellsWolfgang Glienke, Luise Maute, Johannes Wicht, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2008
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in GermanyHolger Gerullis, Lothar Bergmann, Luise Maute, et al.
Annals of Nuclear Medicine|April 15, 2010
Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinomaMarcus Middendorp, Luise Maute, Bruno Sauter, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2014
Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysisLuise Maute, Viktor Grünwald, Steffen Weikert, et al.
Medical Oncology (Northwood, London, England)|April 29, 2009
Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinomaHolger Gerullis, Lothar Bergmann, Luise Maute, et al.
Oncology Research and Treatment|June 17, 2020
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer SocietyLothar Bergmann, Viktor Grünwald, Luise Maute, et al.
Pageof 1